SOURCE: MediJane Holdings Inc.
LONGMONT, CO--(Marketwired - Apr 16, 2014) - MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company") is pleased to announce that Dr. Joseph Cohen has agreed to assume the role of Chief Medical Officer and join the board of directors of the Company.
Dr. Cohen has developed a complimentary and innovative approach to wellness that combines functional medicine with the utilization of natural substances, such as medicinal cannabis and other formulations. Holos Health, a Dr. Cohen supported Medical Marijuana Evaluation facility in Boulder, Colorado, was the recipient of the Best of Boulder Award in 2012 and 2013 for Best Medical Marijuana Evaluations and Best Alternative Health Care Practitioners. Dr. Cohen also holds the position of Chief Medical Advisor to a significant Connecticut licensed medical marijuana company.
"I'm absolutely thrilled to be involved in a project that I'm so passionate about," stated Dr. Cohen. "This industry is on the cusp of fantastic new medical breakthroughs and I'm proud to be working with MediJane to do our part to ensure the long-term sustainability of medical delivery systems for the safe and legal access to medical marijuana."
Having moved to Boulder, Colorado, in 1991, Dr. Cohen practiced obstetrics and gynecology initially with the Boulder Women's Clinic and then formed Full Circle Health Associates, a multi-discipline group that combined conventional and integrative medicine. During that time, Dr. Cohen was both the medical director of the Center for Integrative Therapeutics at Longmont United Hospital, as well as department chair in OB/GYN and pediatrics. Under his direction, integrative approaches such as acupuncture, reiki, and massage therapy were brought into a hospital setting. In 1993, Dr. Cohen was awarded "Best Delivery Man" by Denver Westward magazine. During his 30 years' experience as an obstetrician/gynecologist, he assisted women in approximately 10,000 births.
In 2001, Dr. Cohen left Colorado and began working with women from several different cultures. This included Hispanic women at The Medical Center of Aurora where he worked as a hospitalist, Native American women in Wyoming (Arapaho and Shoshoni tribes) and Maori women in Whanganui, New Zealand. During the past decade he has been studying functional medicine. Since returning to Boulder from New Zealand in 2009, he has integrated medical marijuana into his holistic functional medicine practice.
In addition to carrying a private medical practice in Boulder, Colorado, Dr. Cohen is currently medical director for the Natural Plant Initiative for Cancer Research, Holos Health, and for Journey 2 Life, an alternative and holistic health services provider, and is also a member of the Institute for Functional Medicine. Dr. Cohen received his Doctor of Osteopathy degree in 1979 after completing his residency in obstetrics and gynecology at Bridgeport Hospital in affiliation with Yale University School of Medicine.
About MediJane Holdings Inc. (MJMD)
MediJane Holdings Inc. (MJMD) is in the business of marketing and distributing products within the medicinal marijuana industry, including transdermal patches, capsules, sublingual sprays, and other medical delivery systems. With sales offices opening in California and Colorado, and a planned expansion into a national footprint, MediJane products are designed to give doctors the ability to provide patients accurate and effective doses of cannabinoids to manage and treat pain and other specific illnesses. MediJane's lead product is an innovative non-drowsy "Daytime Pain plus CBD" oral capsule for the treatment of inflammation and chronic, neuropathic, arthritic, and back pain. This smokeless and accurate dose alternative is MediJane's initial launch into the chronic pain management market, which is estimated at over $45 billion annually in North America.
For more information, visit www.medijane.co
Disclaimer/Safe Harbor: Some information in this MediJane Holdings Inc. (MJMD) press release constitutes forward-looking statements or statements which may be deemed or construed to be forward-looking statements. The words "plan", "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to, known and unknown risks, uncertainties and other factors which could cause MJMD's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to MJMD herein are expressly qualified in their entirety by the above-mentioned cautionary statement. MJMD disclaims any obligation to update forward-looking statements contained in this press release, except as may be required by law.